Vassilopoulos et al reported three adult cases, where two were not treated with immunosuppressive drugs before anakinra and one had recurrence after anakinra was tapered. The Double Blind Placebo Controlled Clinical Trial AIRTRIP, shows efficacy of anakinra in treating 11 patients with recurrent pericarditis over 14 months. It is unclear from this study if anakinra should be tapered or not. We suggest that once steroids and immunosuppressive drugs have been discontinued, anakinra should be gradually tapered over months, to avoid relapse. These experiences warrant further long term controlled trials in order to determine the efficacy and appropriate treatment regimen of anakinra for recurrent pericarditis.
However it is unclear what is the incidence of malignancies and whether particular malignancies are more prevalent in RPF. Objectives: The objective of this study was to examine standardized incidence ratios (SIRs) of cancers in patients with retroperitoneal fibrosis (RPF) compared with age-and sex-matched general population. Methods: Medical records of 111 patients diagnosed as having RPF by computed tomography, positron emission tomography and/or histological evaluation were reviewed. Forty one cases of cancers, which were confirmed by biopsies, were identified in 35 patients with RPF. SIRs were calculated for cancers, cancer types, and age at cancer diagnosis and stratified according to RPF-cancer intervals compared with general population in Korea. Results: The mean ± SD age at RPF diagnosis was 59.1±14.9 years, and 69.4% of the patients were male. The cancer SIR (95% confidence intervals) in patients with RPF relative to age-and sex-matched individuals in the general population was 3. were also significantly higher than in general population. Whereas cancers were most frequently developed in the eighth decade of life, the peak SIR was observed in the fifth decade (8.41, 2.29 -21.53). When stratified by RPF-cancer intervals, SIR was 6.85 (4.55 -9.90) within 2 years of RPF diagnosis, while no significant increase in SIR was found out of 2 years. Malignancies (n=28) within 2 year of RPF diagnosis included unspecified urinary organ cancer (n=4), stomach cancer (n=4), lung cancer (n=4), colon cancer (n=3), renal cell cancer (n=2), pancreatic cancer (n=2), unspecified cancer (n=2), rectal cancer (n=1), gallbladder cancer (n=1), non-Hodgkin lymphoma (n=1), multiple myeloma (n=1), prostate cancer (n=1), thyroid cancer (n=1) and gastrointestinal stromal tumor (n=1). Predominant origin of these malignancies were epithelial cell types [transitional cell carcinomas (n=4), adenocarcinoma (n=16)].
Conclusions: RPF was strongly associated with cancers, particularly within 2 years of RPF diagnosis. Our results indicate that cancer screening in patients with RPF should may be performed regularly up to 2 years after RPF diagnosis. Background: Sarcoidosis is a chronic granulomatous disease characterized by non-caseating granuloma formation. It can mimic many rheumatic diseases and/or may be coexist with them. There are limited data in the literature about the association of sarcoidosis with autoimmune diseases. Objectives: The purpose of this study is to determine the frequency and characteristics of autoimmune diseases associated with patients with sarcoidosis. Methods: One hundred and thirty-one sarcoidosis patients folowed-up in single rheumatology center were included in the study. Demographic, clinical, laboratory and radiological data of these cases were evaluated retrospectively. The
